Ozempic and Wegovy

Ozempic and Wegovy (Vision Loss & Blindness):

Weitz & Luxenberg is pursuing cases of severe vision loss in adults who took Ozempic or Wegovy to treat diabetes, weight loss, or for other medical reasons. A large study out of the Harvard Medical School revealed a strong association between these drugs and the development of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION). This is a type of severe damage to the optic nerve causing vision loss and, in some cases, even blindness.

If your client used a semaglutide injection and had a loss in your vision, reach out to us today. We can help you explore your legal options and get you justice for your injury, and the financial compensation you deserve.

Z

Taking Ozempic or Wegovy Can Make Your Clients Blind

The lawsuits are based on the fact that people were not warned that Ozempic or Wegovy were associated with NAION and that the manufacturer knew, or should have known, about this association. Recent studies have raised these concerns. Research “findings suggest an association between semaglutide and NAION.” Another researcher recommend “further data-driven research” is needed on this topic.

“Despite all the hoopla on the benefits of these medications, it is often overlooked that the drugs you can hurt you. Nonarteritic Anterior Ischemic Optic Neuropathy leads to blindness. It is a very serious condition and is a significant cause of blindness” says Ellen Relkin, W&L partner and practice group chair of our firm’s Drug and Medical Device Litigation unit. “After taking Ozempic or Wegovy, some people are developing this unusual condition that damages their vision. They were never warned of these serious risks.”

She continues, “Patients would not suspect that taking a drug to treat diabetes or to lose weight could damage their optic nerve. The connection was observed by astute neuro-ophthalmologists at Harvard who noticed what seemed to be a large number of their patients with NAION and who had been prescribed Ozempic or Wegovy. This prompted these concerned clinicians to conduct a large retrospective matched cohort study of their patients at Massachusetts Eye and Ear in Boston. It is concerning that the patient inserts about Ozempic and Wegovy entirely fail to warn about this devastating condition.”

The attorneys at W&L urge you to contact us if your clients used Ozempic or Wegovy at any time since January 2018 and were diagnosed with NAION.